Gainers
- AnaptysBio ANAB shares moved upwards by 29.7% to $19.5 during Friday's pre-market session. The market value of their outstanding shares is at $593.3 million.
- GlucoTrack GCTK stock rose 25.88% to $0.09. The company's market cap stands at $1.4 million.
- Channel Therapeutics CHRO stock increased by 18.74% to $1.14. The company's market cap stands at $6.8 million.
- Immuron IMRN stock moved upwards by 18.65% to $2.35. The company's market cap stands at $13.3 million.
- Moleculin Biotech MBRX stock increased by 14.36% to $1.99. The company's market cap stands at $6.3 million.
- Impact BioMedical IBO shares rose 13.66% to $1.83. The market value of their outstanding shares is at $21.0 million.
Losers
- BioLine Rx BLRX shares fell 21.6% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $12.7 million.
- Scorpius Holdings SCPX stock declined by 17.78% to $0.31. The market value of their outstanding shares is at $1.5 million.
- AEON Biopharma AEON shares declined by 12.29% to $0.15. The market value of their outstanding shares is at $11.9 million.
- PureTech Health PRTC shares decreased by 7.69% to $16.7. The market value of their outstanding shares is at $399.8 million.
- TransCode Therapeutics RNAZ stock fell 7.17% to $3.11. The company's market cap stands at $2.1 million.
- QT Imaging Holdings QTI shares declined by 6.88% to $0.49. The company's market cap stands at $10.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ANABAnaptysBio Inc
$15.714.52%
BLRXBioLine Rx Ltd
$0.1039-14.8%
CHROChannel Therapeutics Corp
$1.8491.7%
GCTKGlucoTrack Inc
$0.088119.4%
IBOImpact BioMedical Inc
$1.53-5.21%
IMRNImmuron Ltd
$2.169.09%
MBRXMoleculin Biotech Inc
$1.877.47%
PRTCPureTech Health PLC
$17.50-3.26%
QTIQT Imaging Holdings Inc
$0.4682-11.0%
RNAZTransCode Therapeutics Inc
$3.452.99%
SCPXScorpius Holdings Inc
$0.3286-12.8%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in